Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-003512
Filing Date
2023-04-07
Accepted
2023-04-07 16:30:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28615
2 filename2.txt TEXT-EXTRACT 2471
  Complete submission text file 0000000000-23-003512.txt   42686
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filed for) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations